United States Pharmaceuticals

Idenix Pharmaceuticals LLC (IDIX)

Track

Ticker: IDIX Exchange: NSQ
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 31 Jan 2014
Value US$4,485,966.99 | Price 315.16 | Shares 6,617 (-6.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2014-02-04 2014-01-31 B Purchase BAUPOST GROUP LLC/MA Large shareholder
6,617 -6.9%
315.16
US$4,485,967 		6,617 -6.9% 315.16 US$4,485,967
2012-03-20 2012-03-16 S Sale Fanning Paul

SVP, Human Resources

Officer
27,950 +40.0%
316.14
US$3,604,616 		27,950 +40.0% 316.14 US$3,604,616
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
95,903 +21.7%
104.09
US$1,386,527 		95,903 +21.7% 104.09 US$1,386,527
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
493 +0.0%
6.52
US$3,214 		493 +0.0% 6.52 US$3,214
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
436 +0.0%
5.80
US$2,529 		436 +0.0% 5.80 US$2,529
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
883 +0.0%
5.79
US$5,113 		883 +0.0% 5.79 US$5,113
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
7,402 +0.0%
5.46
US$40,415 		7,402 +0.0% 5.46 US$40,415
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
11,433 +0.0%
5.11
US$58,423 		11,433 +0.0% 5.11 US$58,423
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
39 +0.0%
5.10
US$199 		39 +0.0% 5.10 US$199
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
3,093 +0.0%
3.79
US$11,722 		3,093 +0.0% 3.79 US$11,722
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
4,336 +0.0%
3.17
US$13,745 		4,336 +0.0% 3.17 US$13,745
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
232 +0.0%
3.04
US$705 		232 +0.0% 3.04 US$705
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
427 +0.0%
2.97
US$1,268 		427 +0.0% 2.97 US$1,268
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
8,960 +0.0%
2.96
US$26,522 		8,960 +0.0% 2.96 US$26,522
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
3,117 +0.0%
2.90
US$9,039 		3,117 +0.0% 2.90 US$9,039
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
1,321 +0.0%
2.85
US$3,765 		1,321 +0.0% 2.85 US$3,765
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
997 +0.0%
2.78
US$2,772 		997 +0.0% 2.78 US$2,772
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
997 +0.0%
2.69
US$2,682 		997 +0.0% 2.69 US$2,682
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
2,493 +0.0%
2.56
US$6,382 		2,493 +0.0% 2.56 US$6,382
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
366 +0.0%
2.47
US$904 		366 +0.0% 2.47 US$904
2012-02-23 2012-02-23 B Purchase NOVARTIS AG

Indirect 10% Owner
35,735 +0.1%
2.41
US$86,121 		35,735 +0.1% 2.41 US$86,121
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
9,197 +0.0%
5.46
US$50,216 		9,197 +0.0% 5.46 US$50,216
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
2,107 +0.0%
5.11
US$10,767 		2,107 +0.0% 5.11 US$10,767
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
20,228 +0.1%
4.70
US$95,072 		20,228 +0.1% 4.70 US$95,072
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
140 +0.0%
3.79
US$531 		140 +0.0% 3.79 US$531
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
1,146 +0.0%
3.17
US$3,633 		1,146 +0.0% 3.17 US$3,633
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
6,476 +0.0%
2.95
US$19,104 		6,476 +0.0% 2.95 US$19,104
2011-11-22 2011-11-22 B Purchase NOVARTIS AG

Indirect 10% Owner
11,236 +0.0%
2.41
US$27,079 		11,236 +0.0% 2.41 US$27,079
2011-04-13 2011-04-13 B Purchase NOVARTIS AG

Indirect 10% Owner
1,785,714 +5.7%
2.80
US$4,999,999 		1,785,714 +5.7% 2.80 US$4,999,999
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
206 +0.0%
5.11
US$1,053 		206 +0.0% 5.11 US$1,053
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
1,760 +0.0%
3.88
US$6,829 		1,760 +0.0% 3.88 US$6,829
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
860 +0.0%
3.79
US$3,259 		860 +0.0% 3.79 US$3,259
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
897 +0.0%
2.96
US$2,655 		897 +0.0% 2.96 US$2,655
2011-02-25 2011-02-25 B Purchase NOVARTIS AG

Indirect 10% Owner
17,270 +0.1%
2.41
US$41,621 		17,270 +0.1% 2.41 US$41,621
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
486 +0.0%
5.46
US$2,654 		486 +0.0% 5.46 US$2,654
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
1,332 +0.0%
5.11
US$6,807 		1,332 +0.0% 5.11 US$6,807
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
165 +0.0%
3.79
US$625 		165 +0.0% 3.79 US$625
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
44 +0.0%
2.96
US$130 		44 +0.0% 2.96 US$130
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
822 +0.0%
2.64
US$2,170 		822 +0.0% 2.64 US$2,170
2010-11-26 2010-11-26 B Purchase NOVARTIS AG

Indirect 10% Owner
14,234 +0.0%
2.41
US$34,304 		14,234 +0.0% 2.41 US$34,304
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
813 +0.0%
3.79
US$3,081 		813 +0.0% 3.79 US$3,081
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
91 +0.0%
3.04
US$277 		91 +0.0% 3.04 US$277
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
262 +0.0%
2.96
US$776 		262 +0.0% 2.96 US$776
2010-08-23 2010-08-23 B Purchase NOVARTIS AG

Indirect 10% Owner
36,048 +0.1%
2.41
US$86,876 		36,048 +0.1% 2.41 US$86,876
2010-06-08 2010-06-08 B Purchase NOVARTIS AG

Indirect 10% Owner
1,351 +0.0%
2.41
US$3,256 		1,351 +0.0% 2.41 US$3,256
2010-02-26 2010-02-26 B Purchase NOVARTIS AG

Indirect 10% Owner
1,872 +0.0%
2.41
US$4,512 		1,872 +0.0% 2.41 US$4,512
2009-12-17 2009-12-16 B Purchase HODGSON THOMAS R Non-Executive Director
10,387 +22.2%
2.12
US$22,020 		10,387 +22.2% 2.12 US$22,020
2009-12-17 2009-12-15 B Purchase HODGSON THOMAS R Non-Executive Director
15,000 +47.2%
2.15
US$32,250 		15,000 +47.2% 2.15 US$32,250
2009-12-14 2009-12-14 B Purchase HODGSON THOMAS R Non-Executive Director
11,000 +52.9%
2.12
US$23,320 		11,000 +52.9% 2.12 US$23,320
2009-12-14 2009-12-11 B Purchase HODGSON THOMAS R Non-Executive Director
8,613 +70.6%
2.08
US$17,915 		8,613 +70.6% 2.08 US$17,915
2009-12-14 2009-12-10 B Purchase HODGSON THOMAS R Non-Executive Director
5,000 +69.4%
2.05
US$10,250 		5,000 +69.4% 2.05 US$10,250
2009-11-24 2009-11-24 B Purchase Weidenbruch John

Ex. VP, Gen. Counsel and Secr.

Officer
20,000 +133.3%
1.89
US$37,800 		20,000 +133.3% 1.89 US$37,800
2009-08-24 2009-08-21 B Purchase NOVARTIS AG

INDIRECT 10% OWNER
3,431 +0.0%
2.41
US$8,269 		3,431 +0.0% 2.41 US$8,269
2009-05-29 2009-05-29 B Purchase NOVARTIS AG

INDIRECT 10% OWNER
2,451 +0.0%
2.62
US$6,422 		2,451 +0.0% 2.62 US$6,422
2009-02-23 2009-02-23 B Purchase NOVARTIS AG

Indirect 10% owner
5,444 +0.0%
2.41
US$13,120 		5,444 +0.0% 2.41 US$13,120
2008-11-25 2008-11-19 B Purchase NOVARTIS AG

INDIRECT 10% OWNER
4,747 +0.0%
4.05
US$19,225 		4,747 +0.0% 4.05 US$19,225
2008-09-03 2008-09-02 B Purchase NOVARTIS AG Large shareholder
4,654 +0.0%
2.93
US$13,636 		4,654 +0.0% 2.93 US$13,636
2008-05-30 2008-05-29 B Purchase NOVARTIS AG Large shareholder
924 +0.0%
2.41
US$2,227 		924 +0.0% 2.41 US$2,227
2008-03-13 2008-03-11 B Purchase Mayers Douglas L

EVP and Chief Medical Officer

Officer
30,000 +inf%
4.45
US$133,500 		30,000 +inf% 4.45 US$133,500
2007-07-19 2007-07-13 B Purchase Koppy Susan

Sr. VP, Business and Corp Dev.

Officer
400 +160.0%
3.84
US$1,536 		400 +160.0% 3.84 US$1,536
2006-06-08 2006-06-06 B Purchase NOVARTIS AG Large shareholder
365 +0.0%
20.48
US$7,475 		365 +0.0% 20.48 US$7,475
2006-05-11 2006-05-09 B Purchase Sommadossi Jean-Pierre

President, CEO, Chairman

Executive Director
10,000 +0.5%
9.13
US$91,300 		10,000 +0.5% 9.13 US$91,300
2006-05-10 2006-05-08 B Purchase Koppy Susan

Sr. VP, Business and Corp Dev.

Officer
200 +400.0%
9.26
US$1,852 		200 +400.0% 9.26 US$1,852
2006-04-06 2006-04-04 B Purchase NOVARTIS AG Large shareholder
2,938 +0.0%
16.23
US$47,684 		2,938 +0.0% 16.23 US$47,684
2005-11-16 2005-11-14 S Sale Pollard-Knight Denise Non-Executive Director
629,498 -67.6%
20.61
US$12,973,954 		629,498 -67.6% 20.61 US$12,973,954
2005-11-02 2005-10-31 B Purchase NOVARTIS AG Large shareholder
3,939,131 +14.4%
20.61
US$81,185,490 		3,939,131 +14.4% 20.61 US$81,185,490
2004-07-29 2004-07-27 B Purchase
HODGSON THOMAS R
7,200 +20.5%
14.00
US$100,800 		7,200 +20.5% 14.00 US$100,800
2004-07-29 2004-07-27 B Purchase
Corcoran Andrea

Exec. VP, Legal and Admin.
7,200 +12.8%
14.00
US$100,800 		7,200 +12.8% 14.00 US$100,800
2004-07-29 2004-07-27 B Purchase
3.7
Sommadossi Jean-Pierre

President, CEO, Chairman

Executive Director
6,364 +0.3%
14.00
US$89,096 		6,364 +0.3% 14.00 US$89,096
2004-07-29 2004-07-27 B Purchase
3.2
Macdonald Guy

Executive VP, Operations
10,000 +inf%
14.00
US$140,000 		10,000 +inf% 14.00 US$140,000
2004-07-29 2004-07-27 B Purchase
1.4
Arkowitz David

Chief Financial Officer
8,000 +inf%
14.00
US$112,000 		8,000 +inf% 14.00 US$112,000
2004-07-29 2004-07-27 B Purchase
3.0
BARSHEFSKY CHARLENE
20,000 +inf%
14.00
US$280,000 		20,000 +inf% 14.00 US$280,000
2004-07-29 2004-07-27 B Purchase
CRAMB CHARLES W JR
7,200 +inf%
14.00
US$100,800 		7,200 +inf% 14.00 US$100,800
2004-07-29 2004-07-27 B Purchase
Egan James

Sr. VP, Business and Corp Dev
13,400 +6.2%
14.00
US$187,600 		13,400 +6.2% 14.00 US$187,600
2004-07-28 2004-07-27 S Sale
3.1
GADICKE ANSBERT
Large shareholder
508,371 -9.6%
14.00
US$7,117,194 		508,371 -9.6% 14.00 US$7,117,194
Explore more

More insider trading research around Idenix Pharmaceuticals LLC

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America